Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:February 2, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:February 2, 2023Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:July 14, 2020Unknown status
Condition(s):HypersomnolenceLast Updated:February 9, 2024Recruiting
Condition(s):Drug AbuseLast Updated:April 5, 2019Completed
Condition(s):Cocaine Addiction; Cocaine AbuseLast Updated:July 2, 2017Withdrawn
Condition(s):DeliriumLast Updated:November 1, 2021Terminated
Condition(s):Attention-Deficit / Hyperactivity DisorderLast Updated:March 28, 2014Completed
Condition(s):Attention Deficit Hyperactivity Disorder; Problem BehaviorLast Updated:November 1, 2022Recruiting
Condition(s):Brain InjuryLast Updated:September 2, 2016Unknown status
Condition(s):Attention Deficit Disorder With Hyperactivity; Developmental Coordination DisorderLast Updated:November 27, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.